SCHEMBL7699566

SCHEMBL7699566

CCOC(=O)C1=Cc2cccc(NS(=O)(=O)N(C)C)c2OCC1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
TSHR P16473 6/20 0.35
KMT2A Q03164 1/20 0.35
HTT P42858 3/20 0.35
KDM4E B2RXH2 2/20 0.35
GAA P10253 2/20 0.35
NPC1 O15118 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
POLB P06746 3/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPK10 P53779 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
TP53 P04637 2/20 0.34
HSD17B10 Q99714 1/20 0.34
PIK3C3 Q8NEB9 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RECQL P46063 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7386010 0.89 TSHR (0.45) LMNATSHRKMT2AHTTKDM4E
SCHEMBL7700693 0.88 CA1 (0.42) LMNATSHRKMT2AHTTKDM4E
SCHEMBL7388616 0.83 TSHR (0.45) LMNATSHRKMT2AHTTKDM4E
SCHEMBL7695368 0.82 ALDH1A1 (0.47) TSHRKMT2AHTTNPC1ALDH1A1
SCHEMBL7382828 0.81 L3MBTL1 (0.40) LMNATSHRKMT2AHTTKDM4E
SCHEMBL7388954 0.81 ALDH1A1 (0.41) LMNATSHRKMT2AHTTKDM4E
SCHEMBL7697790 0.80 ALDH1A1 (0.35) LMNATSHRKMT2AKDM4EGAA
SCHEMBL7385104 0.79 NOTUM (0.40) LMNATSHRKMT2AKDM4ENPC1
SCHEMBL7385304 0.79 MAPT (0.39) TSHRKMT2AHTTKDM4EGAA
SCHEMBL7700172 0.78 ALDH1A1 (0.35) TSHRKMT2AKDM4EGAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346527-B1 1-BENZOXEPIN DERIVATIVES USED IN THE PREVENTION OF SODIUM AND HYDROGEN ION EXCHANGE; CARDIOVASCULAR, KIDNEY AND BRAIN DISORDER TREATMENT; ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-12 US disclosed
EP-1073650-A1 GUANIDINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-07 EP disclosed
WO-1999055690-A1 GUANIDINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-11-04 WO disclosed